ENDPOINTS

Innovent brings a new mechanism to obesity market with China approval

Innovent said on Friday that its obesity medicine mazdutide has been approved in China, becoming the first dual GLP-1/glucagon agonist to be greenlit for the disease anywhere in the world. ...

Jun 27, 2025 - 15:32
 0
Innovent brings a new mechanism to obesity market with China approval
Innovent said on Friday that its obesity medicine mazdutide has been approved in China, becoming the first dual GLP-1/glucagon agonist to be greenlit for the disease anywhere in the world. ...
Read More

Tags:

Previous Article

When Did Nature Burst Into Vivid Color?

Next Article

Fossil fungi trapped in amber reveal ancient origin of parasitic zombie-ants

Related Posts

GoodRx goes toe-to-toe with Hims, Ro as it pushes into ED treatment

GoodRx goes toe-to-toe with Hims, Ro as it pushes into ...

Jun 10, 2025  0

Schott Pharma's €100M+ Hungary expansion; Antheia’s $56M Series C raise

Schott Pharma's €100M+ Hungary expansion; Antheia’s $56...

Jun 5, 2025  0

Trump axes Moderna bird flu pact worth more than $750M

Trump axes Moderna bird flu pact worth more than $750M

May 29, 2025  0